{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T11:39:44Z","timestamp":1789213184208,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012399","name":"Biomedical Advanced Research and Development Authority","doi-asserted-by":"publisher","award":["Contract No. HHSO100201700012C"],"award-info":[{"award-number":["Contract No. HHSO100201700012C"]}],"id":[{"id":"10.13039\/100012399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Direct at line monitoring of live virus particles in commercial manufacturing of vaccines is challenging due to their small size. Detection of malformed or damaged virions with reduced potency is rate-limited by release potency assays with long turnaround times. Thus, preempting batch failures caused by out of specification potency results is almost impossible. Much needed are in-process tools that can monitor and detect compromised viral particles in live-virus vaccines (LVVs) manufacturing based on changes in their biophysical properties to provide timely measures to rectify process stresses leading to such damage. Using ERVEBO, MSD\u2019s Ebola virus vaccine as an example, here we describe a flow virometry assay that can quickly detect damaged virus particles and provide mechanistic insight into process parameters contributing to the damage. Furthermore, we describe a 24-h high throughput infectivity assay that can be used to correlate damaged particles directly to loss in viral infectivity (potency) in-process. Collectively, we provide a set of innovative tools to enable rapid process development, process monitoring, and control strategy implementation in large scale LVV manufacturing.<\/jats:p>","DOI":"10.1038\/s41598-021-86688-z","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T10:03:08Z","timestamp":1617271388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Flow virometry for process monitoring of live virus vaccines-lessons learned from ERVEBO"],"prefix":"10.1038","volume":"11","author":[{"given":"Geoffri","family":"Ricci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Minsker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin","family":"Kapish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Osborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Davide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph P.","family":"Califano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrell","family":"Sehlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard R.","family":"Rustandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Lawrence W.","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Vlasak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy D.","family":"Culp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Baudy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malini","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"issue":"47","key":"86688_CR1","doi-asserted-by":"publisher","first-page":"6970","DOI":"10.1016\/j.vaccine.2019.05.064","volume":"37","author":"RGF Alvim","year":"2019","unstructured":"Alvim, R. G. F., Itabaiana, I. Jr. & Castilho, L. R. Zika virus-like particles (VLPs): Stable cell lines and continuous perfusion processes as a new potential vaccine manufacturing platform. Vaccine 37(47), 6970\u20136977 (2019).","journal-title":"Vaccine"},{"issue":"9","key":"86688_CR2","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1586\/14760584.2015.1067144","volume":"14","author":"LE Gallo-Ramirez","year":"2015","unstructured":"Gallo-Ramirez, L. E. et al. Bioreactor concepts for cell culture-based viral vaccine production. Expert Rev. Vaccines 14(9), 1181\u20131195 (2015).","journal-title":"Expert Rev. Vaccines"},{"key":"86688_CR3","first-page":"155188","volume":"2019","author":"HH Mao","year":"2019","unstructured":"Mao, H. H. & Chao, S. Advances in vaccines. Adv. Biochem. Eng. Biotechnol. 2019, 155188 (2019).","journal-title":"Adv. Biochem. Eng. Biotechnol."},{"issue":"8","key":"86688_CR4","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1080\/21645515.2018.1460297","volume":"14","author":"A Perez Rubio","year":"2018","unstructured":"Perez Rubio, A. & Eiros, J. M. Cell culture-derived flu vaccine: Present and future. Hum. Vaccin. Immunother. 14(8), 1874\u20131882 (2018).","journal-title":"Hum. Vaccin. Immunother."},{"issue":"33","key":"86688_CR5","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.1016\/j.vaccine.2017.06.003","volume":"35","author":"S Plotkin","year":"2017","unstructured":"Plotkin, S. et al. The complexity and cost of vaccine manufacturing: An overview. Vaccine 35(33), 4064\u20134071 (2017).","journal-title":"Vaccine"},{"issue":"2","key":"86688_CR6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jviromet.2010.04.006","volume":"167","author":"PS Bose","year":"2010","unstructured":"Bose, P. S. et al. Development of a high-throughput rubella virus infectivity assay based on viral activation of caspases. J. Virol. Methods 167(2), 199\u2013204 (2010).","journal-title":"J. Virol. Methods"},{"key":"86688_CR7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0065-3527(08)60689-2","volume":"8","author":"PD Cooper","year":"1961","unstructured":"Cooper, P. D. The plaque assay of animal viruses. Adv. Virus Res. 8, 319\u2013378 (1961).","journal-title":"Adv. Virus Res."},{"key":"86688_CR8","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3181\/00379727-112-28111","volume":"112","author":"AL Kisch","year":"1963","unstructured":"Kisch, A. L. & Johnson, K. M. A plaque assay for respiratory syncytial virus. Proc. Soc. Exp. Biol. Med. 112, 583\u2013589 (1963).","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"86688_CR9","first-page":"314","volume":"89","author":"KR Rozee","year":"1963","unstructured":"Rozee, K. R. et al. A plaque method for rubella virus assay. Can. Med. Assoc. J. 89, 314\u2013315 (1963).","journal-title":"Can. Med. Assoc. J."},{"issue":"3","key":"86688_CR10","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1128\/JVI.01765-17","volume":"92","author":"R Lippe","year":"2018","unstructured":"Lippe, R. Flow virometry: a powerful tool to functionally characterize viruses. J. Virol. 92(3), 2018 (2018).","journal-title":"J. Virol."},{"issue":"1","key":"86688_CR11","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/s41598-017-00935-w","volume":"7","author":"A Arakelyan","year":"2017","unstructured":"Arakelyan, A. et al. Flow virometry analysis of envelope glycoprotein conformations on individual HIV virions. Sci. Rep. 7(1), 948 (2017).","journal-title":"Sci. Rep."},{"issue":"9","key":"86688_CR12","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1172\/JCI67042","volume":"123","author":"A Arakelyan","year":"2013","unstructured":"Arakelyan, A. et al. Nanoparticle-based flow virometry for the analysis of individual virions. J. Clin. Invest. 123(9), 3716\u20133727 (2013).","journal-title":"J. Clin. Invest."},{"key":"86688_CR13","first-page":"e55020","volume":"119","author":"A Arakelyan","year":"2017","unstructured":"Arakelyan, A. et al. Flow virometry to analyze antigenic spectra of virions and extracellular vesicles. J. Vis. Exp. 119, e55020 (2017).","journal-title":"J. Vis. Exp."},{"key":"86688_CR14","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.virol.2017.02.016","volume":"505","author":"MM Bonar","year":"2017","unstructured":"Bonar, M. M. & Tilton, J. C. High sensitivity detection and sorting of infectious human immunodeficiency virus (HIV-1) particles by flow virometry. Virology 505, 80\u201390 (2017).","journal-title":"Virology"},{"issue":"10","key":"86688_CR15","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1128\/JVI.00320-17","volume":"91","author":"N El Bilali","year":"2017","unstructured":"El Bilali, N. et al. Quantitative evaluation of protein heterogeneity within herpes simplex virus 1 particles. J. Virol. 91(10), 2017 (2017).","journal-title":"J. Virol."},{"key":"86688_CR16","doi-asserted-by":"publisher","first-page":"6022","DOI":"10.1038\/ncomms7022","volume":"6","author":"R Gaudin","year":"2015","unstructured":"Gaudin, R. & Barteneva, N. S. Sorting of small infectious virus particles by flow virometry reveals distinct infectivity profiles. Nat. Commun. 6, 6022 (2015).","journal-title":"Nat. Commun."},{"key":"86688_CR17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/978-1-4939-9814-2_16","volume":"2060","author":"B Khadivjam","year":"2020","unstructured":"Khadivjam, B., El Bilali, N. & Lippe, R. Analysis and sorting of individual hsv-1 particles by flow virometry. Methods Mol. Biol. 2060, 289\u2013303 (2020).","journal-title":"Methods Mol. Biol."},{"key":"86688_CR18","first-page":"202","volume":"6","author":"JY Khalil","year":"2016","unstructured":"Khalil, J. Y. et al. Flow cytometry sorting to separate viable giant viruses from amoeba co-culture supernatants. Front. Cell Infect. Microbiol. 6, 202 (2016).","journal-title":"Front. Cell Infect. Microbiol."},{"issue":"7","key":"86688_CR19","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/j.vaccine.2019.11.087","volume":"38","author":"E Puente-Massaguer","year":"2020","unstructured":"Puente-Massaguer, E., Lecina, M. & G\u00f2dia, F. Application of advanced quantification techniques in nanoparticle-based vaccine development with the Sf9 cell baculovirus expression system. Vaccine 38(7), 1849\u20131859 (2020).","journal-title":"Vaccine"},{"issue":"20","key":"86688_CR20","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1016\/j.vaccine.2016.03.067","volume":"34","author":"J Vlasak","year":"2016","unstructured":"Vlasak, J. et al. Use of flow cytometry for characterization of human cytomegalovirus vaccine particles. Vaccine 34(20), 2321\u20132328 (2016).","journal-title":"Vaccine"},{"key":"86688_CR21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ymeth.2017.12.011","volume":"134\u2013135","author":"JLR Zamora","year":"2018","unstructured":"Zamora, J. L. R. & Aguilar, H. C. Flow virometry as a tool to study viruses. Methods 134\u2013135, 87\u201397 (2018).","journal-title":"Methods"},{"key":"86688_CR22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.virol.2015.10.021","volume":"488","author":"S Zicari","year":"2016","unstructured":"Zicari, S. et al. Evaluation of the maturation of individual Dengue virions with flow virometry. Virology 488, 20\u201327 (2016).","journal-title":"Virology"},{"issue":"35PtA","key":"86688_CR23","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.1016\/j.vaccine.2017.05.097","volume":"35","author":"BG Coller","year":"2017","unstructured":"Coller, B. G. et al. Clinical development of a recombinant Ebola vaccine in the midst of an unprecedented epidemic. Vaccine 35(35PtA), 4465\u20134469 (2017).","journal-title":"Vaccine"},{"key":"86688_CR24","doi-asserted-by":"publisher","first-page":"100009","DOI":"10.1016\/j.jvacx.2019.100009","volume":"1","author":"TP Monath","year":"2019","unstructured":"Monath, T. P. et al. rVSVDeltaG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk\/benefit assessment. Vaccine X 1, 100009 (2019).","journal-title":"Vaccine X"},{"issue":"5728","key":"86688_CR25","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1126\/science.1110656","volume":"308","author":"K Chandran","year":"2005","unstructured":"Chandran, K. et al. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308(5728), 1643\u20131645 (2005).","journal-title":"Science"},{"issue":"6","key":"86688_CR26","doi-asserted-by":"publisher","first-page":"621","DOI":"10.2217\/fvl.09.56","volume":"4","author":"JE Lee","year":"2009","unstructured":"Lee, J. E. & Saphire, E. O. Ebolavirus glycoprotein structure and mechanism of entry. Fut. Virol. 4(6), 621\u2013635 (2009).","journal-title":"Fut. Virol."},{"issue":"24","key":"86688_CR27","doi-asserted-by":"publisher","first-page":"13378","DOI":"10.1128\/JVI.01170-07","volume":"81","author":"RL Kaletsky","year":"2007","unstructured":"Kaletsky, R. L., Simmons, G. & Bates, P. Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity. J. Virol. 81(24), 13378\u201313384 (2007).","journal-title":"J. Virol."},{"issue":"45","key":"86688_CR28","doi-asserted-by":"publisher","first-page":"7166","DOI":"10.1016\/j.vaccine.2020.08.001","volume":"38","author":"K Minsker","year":"2020","unstructured":"Minsker, K. et al. Characterization of rVSVDeltaG-ZEBOV-GP glycoproteins using automated capillary western blotting. Vaccine 38(45), 7166\u20137174 (2020).","journal-title":"Vaccine"},{"key":"86688_CR29","doi-asserted-by":"crossref","first-page":"e2947","DOI":"10.1002\/btpr.2947","volume":"36","author":"D Yilmaz","year":"2019","unstructured":"Yilmaz, D. et al. Application of Raman spectroscopy in monoclonal antibody producing continuous systems for downstream process intensification. Biotechnol. Prog. 36, e2947 (2019).","journal-title":"Biotechnol. Prog."},{"key":"86688_CR30","doi-asserted-by":"publisher","first-page":"e2977","DOI":"10.1002\/btpr.2977","volume":"36","author":"C Rafferty","year":"2020","unstructured":"Rafferty, C. et al. Analysis of chemometric models applied to Raman spectroscopy for monitoring key metabolites of cell culture. Biotechnol. Prog. 36, e2977 (2020).","journal-title":"Biotechnol. Prog."},{"issue":"1","key":"86688_CR31","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/bit.27197","volume":"117","author":"C Rafferty","year":"2020","unstructured":"Rafferty, C. et al. Raman spectroscopy as a method to replace off-line pH during mammalian cell culture processes. Biotechnol. Bioeng. 117(1), 146\u2013156 (2020).","journal-title":"Biotechnol. Bioeng."},{"issue":"8 Pt 2","key":"86688_CR32","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1093\/clinchem\/46.8.1221","volume":"46","author":"M Brown","year":"2000","unstructured":"Brown, M. & Wittwer, C. Flow cytometry: principles and clinical applications in hematology. Clin. Chem. 46(8 Pt 2), 1221\u20131229 (2000).","journal-title":"Clin. Chem."},{"issue":"2","key":"86688_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/cyto.a.22795","volume":"89","author":"U Erdbrugger","year":"2016","unstructured":"Erdbrugger, U. & Lannigan, J. Analytical challenges of extracellular vesicle detection: A comparison of different techniques. Cytometry A 89(2), 123\u2013134 (2016).","journal-title":"Cytometry A"},{"issue":"9","key":"86688_CR34","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/cyto.a.22494","volume":"85","author":"U Erdbrugger","year":"2014","unstructured":"Erdbrugger, U. et al. Imaging flow cytometry elucidates limitations of microparticle analysis by conventional flow cytometry. Cytometry A 85(9), 756\u2013770 (2014).","journal-title":"Cytometry A"},{"key":"86688_CR35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ymeth.2016.09.018","volume":"112","author":"J Lannigan","year":"2017","unstructured":"Lannigan, J. & Erdbruegger, U. Imaging flow cytometry for the characterization of extracellular vesicles. Methods 112, 55\u201367 (2017).","journal-title":"Methods"},{"issue":"2","key":"86688_CR36","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/cyto.a.22814","volume":"89","author":"J Lannigan","year":"2016","unstructured":"Lannigan, J. & Zucker, R. Measurement of extracellular vesicles and other submicron size particles by flow cytometry. Cytometry A 89(2), 109\u201310 (2016).","journal-title":"Cytometry A"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-86688-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-86688-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-86688-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T13:00:41Z","timestamp":1698843641000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-86688-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["86688"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-86688-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]},"assertion":[{"value":"23 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7432"}}